A precise number can look authoritative even when its source is unclear. Online descriptions of no-DAC CJC often repeat a short half-life and then use it to justify a schedule. Before accepting that reasoning, ask whether the number was actually measured in people receiving the same defined molecule.
The widely cited 2006 healthy-adult CJC study examined the long-acting construct. It is not a human pharmacokinetic study of a retail no-DAC preparation. The FDA's 2024 assessment also separated CJC-related substances rather than treating their evidence as identical.
A 2016 analytical study developed a method for detecting several GHRH-related peptides in human plasma and investigated their behavior using laboratory and animal experiments. The abstract's human exposure example involved sermorelin, not no-DAC CJC-1295. Its rat sampling and assay detection observations therefore do not supply a human no-DAC pharmacokinetic estimate. Primary analytical study, PMID 26879649
Trace the number all the way back
A useful citation should identify the measured analyte, species, route, formulation and calculation. A webpage linking to a paper is not enough if the paper investigated a different intervention. Repetition across many websites may reflect copying rather than independent confirmation.
Half-life itself also needs context. It describes a concentration-time relationship, not the length of every downstream effect. A proposed hormone response or symptom timeline cannot be read directly from a single elimination parameter.
A shorter-acting design may be a reasonable pharmacological concept, but a concept does not establish a precise human value. It is better to state that a matching measurement has not been verified than to supply a confidently specific number with an unrelated citation.
This matters because the unsupported number often becomes the foundation for additional claims about frequency, fasting or predictable reversibility. Each extra recommendation inherits the uncertainty of the original figure and adds assumptions of its own.
A numerical claim is reliable only when the underlying experiment supports it; the source must match the molecule and setting being discussed. These sources do not provide a validated personal no-DAC CJC schedule. That limitation cannot be resolved by replacing one unverified timing rule with another.